Literature DB >> 11211064

SF-36: evaluation of quality of life in severe and mild insomniacs compared with good sleepers.

D Léger1, K Scheuermaier, P Philip, M Paillard, C Guilleminault.   

Abstract

OBJECTIVE: Despite many studies, the impact of chronic insomnia on daytime functioning is not well understood. The aim of our study was to detect this impact by evaluating quality of life (QoL) using a validated instrument, the 36-item Short Form Health Survey of the Medical Outcomes Study (SF-36), in three matched groups of severe insomniacs, mild insomniacs, and good sleepers selected from the general population.
METHODS: Three matched groups of 240 severe insomniacs, 422 mild insomniacs, and 391 good sleepers were recruited from the general French population after eliminating those with DSM-IV criteria for anxiety or depression. All subjects were asked to complete the SF-36. Scores for each QoL dimension were calculated and compared statistically among the three groups.
RESULTS: Severe insomniacs had lower QoL scores in eight dimensions of the SF-36 than mild insomniacs and good sleepers. Mild insomniacs had lower scores in the same eight dimensions when compared with good sleepers. No dimension was significantly more altered than the other.
CONCLUSIONS: The mental health status and role of emotional QoL dimensions were worse in severe and mild insomniacs than in good sleepers. This result held even though we screened for psychiatric diseases, which shows a clear interrelation between insomnia and emotional state. General health status was also worse in severe and mild insomniacs than in good sleepers. However, we could conclude only that insomnia was related to a worse health status and not whether it was a cause or consequence of this worse health status. Finally, the degradation of QoL scores was correlated with the severity of insomnia.

Entities:  

Mesh:

Year:  2001        PMID: 11211064     DOI: 10.1097/00006842-200101000-00006

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  85 in total

1.  Treatment of insomnia in Parkinson's disease: a controlled trial of eszopiclone and placebo.

Authors:  Matthew Menza; Roseanne DeFronzo Dobkin; Humberto Marin; Michael Gara; Karina Bienfait; Allison Dicke; Cynthia L Comella; Charles Cantor; Lee Hyer
Journal:  Mov Disord       Date:  2010-08-15       Impact factor: 10.338

2.  Sleep Health and Appropriate Use of OTC Sleep Aids in Older Adults-Recommendations of a Gerontological Society of America Workgroup.

Authors:  Steven M Albert; Thomas Roth; Michael Toscani; Michael V Vitiello; Phyllis Zee
Journal:  Gerontologist       Date:  2015-10-28

3.  Psychometric evaluation of the Chinese version of the Pittsburgh Sleep Quality Index (CPSQI) in primary insomnia and control subjects.

Authors:  Pei-Shan Tsai; Shu-Yi Wang; Mei-Yeh Wang; Chein-Tien Su; Tsung-Tsair Yang; Chun-Jen Huang; Su-Chen Fang
Journal:  Qual Life Res       Date:  2005-10       Impact factor: 4.147

4.  The Flinders Fatigue Scale: preliminary psychometric properties and clinical sensitivity of a new scale for measuring daytime fatigue associated with insomnia.

Authors:  Michael Gradisar; Leon Lack; Hayley Richards; Jodie Harris; Julie Gallasch; Michelle Boundy; Anna Johnston
Journal:  J Clin Sleep Med       Date:  2007-12-15       Impact factor: 4.062

5.  The association between sleep duration and self-rated health in the Korean general population.

Authors:  Jae-Hyun Kim; Kyung Ran Kim; Kyoung Hee Cho; Ki-Bong Yoo; Jeoung A Kwon; Eun-Cheol Park
Journal:  J Clin Sleep Med       Date:  2013-10-15       Impact factor: 4.062

6.  Randomized controlled trial of pharmacological replacement of melatonin for sleep disruption in individuals with tetraplegia.

Authors:  Jamie M Zeitzer; Ban Ku; Doug Ota; B Jenny Kiratli
Journal:  J Spinal Cord Med       Date:  2013-10-24       Impact factor: 1.985

7.  Correlation between degree and quality of sleep disturbance and the level of neuropsychiatric impairment in patients with liver cirrhosis.

Authors:  Jayanta Samanta; Radha K Dhiman; Amit Khatri; Kiran K Thumburu; Sandeep Grover; Ajay Duseja; Yogesh Chawla
Journal:  Metab Brain Dis       Date:  2013-03-15       Impact factor: 3.584

8.  Vagal regulation, cortisol, and sleep disruption in women with metastatic breast cancer.

Authors:  Oxana Palesh; Jamie M Zeitzer; Ansgar Conrad; Janine Giese-Davis; Karen M Mustian; Varinia Popek; Karen Nga; David Spiegel
Journal:  J Clin Sleep Med       Date:  2008-10-15       Impact factor: 4.062

9.  Association of insomnia with quality of life, work productivity, and activity impairment.

Authors:  Susan C Bolge; Justin F Doan; Hema Kannan; Robert W Baran
Journal:  Qual Life Res       Date:  2009-03-14       Impact factor: 4.147

10.  Evaluation of the reliability and validity of the Medical Outcomes Study sleep scale in patients with painful diabetic peripheral neuropathy during an international clinical trial.

Authors:  Muriel Viala-Danten; Susan Martin; Isabelle Guillemin; Ron D Hays
Journal:  Health Qual Life Outcomes       Date:  2008-12-17       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.